Analytical Data
-
Gene name
GPM6B
- Application
-
Alternative Names
GPM6B; M6B; Neuronal membrane glycoprotein M6-b; M6b
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13491
-
Expression Region
1-305aa
-
AA Sequence
MKPAMETAAEENTEQSQERKVNSRAEMEIGRYHWMYPGSKNHQYHPVPTLGDRASPLSSPGCFECCIKCLGGVPYASLVATILCFSGVALFCGCGHVALAGTVAILEQHFSTNASDHALLSEVIQLMQYVIYGIASFFFLYGIILLAEGFYTTSAVKELHGEFKTTACGRCISGMFVFLTYVLGVAWLGVFGFSAVPVFMFYNIWSTCEVIKSPQTNGTTGVEQICVDIRQYGIIPWNAFPGKICGSALENICNTNEFYMSYHLFIVACAGAGATVIALLIYMMATTYNYAVLKFKSREDCCTKF
-
Molecular Weight
59.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPM6B, a member of the glycoprotein M6 family, plays a crucial role in the development and functioning of the nervous system. It is a membrane protein that is predominantly expressed in neuronal tissues and is implicated in various physiological processes, including neuronal differentiation, synaptic plasticity, and cell signaling. Recent studies have highlighted GPM6B's involvement in neurodegenerative diseases, making it a potential biomarker and therapeutic target. Research has shown that GPM6B interacts with various signaling pathways, influencing cellular responses to external stimuli and contributing to the maintenance of neuronal integrity. Understanding the structure and function of GPM6B is essential for elucidating its role in health and disease. Scientists have turned to recombinant protein techniques to produce GPM6B in a controlled environment, facilitating advanced studies on its structure-function relationship and interactions with other cellular components. This research aims to unlock the mysteries of GPM6B’s biological functions and its potential therapeutic applications, particularly in the context of neurodegenerative conditions, where modulation of its activity could lead to innovative treatments.











